Results 71 to 80 of about 6,905 (159)
Human metapneumovirus (hMPV) infections pose a serious health risk to young children, particularly in cases of premature birth. No licensed vaccine exists and there is no standard treatment for hMPV infections apart from supportive hospital care. We describe the production of a Sendai virus (SeV) recombinant that carries a gene for a truncated hMPV ...
Charles J, Russell +8 more
openaire +2 more sources
The study explored the clinical characteristics and risk factors of HBoV‐positive severe pneumonia in children. These findings indicate that HBoV can be identified in respiratory samples from children with severe pneumonia, denoting its role as a viral pathogen in hospitalized children with this condition.
Jing Liao +6 more
wiley +1 more source
Human Metapneumovirus (HMPV) is a leading respiratory pathogen that causes lower respiratory tract infections worldwide. Acute HMPV infection induces an exacerbated inflammatory neutrophilic response leading to bronchiolitis and pneumonia.
Nagarjuna R. Cheemarla +1 more
doaj +1 more source
GLAMPING—A POST-PANDEMIC TOURISM MODEL: FROM THEORETICAL DEFINITION TO SPATIO-TEMPORAL MAPPING IN THE SOUTH-WEST OLTENIA REGION, ROMANIA [PDF]
Glamping, which brings together the comfort of a luxury hotel and natural environments, represents a tourism model enabling the relaunch of post-COVID-19 tourism, thus contributing to the sustainable development of tourism in Oltenia.
DRĂGULEASA IONUȚ-ADRIAN +4 more
doaj
Human metapneumovirus (hMPV) is a leading cause of viral lower respiratory tract disease in children and adults. The hMPV fusion protein F is a trimeric class I fusion protein that is initially synthesized as a precursor (F0) and requires proteolytic ...
Marlies Ballegeer +10 more
doaj +1 more source
Human Metapneumovirus Infection among Children Hospitalized with Acute Respiratory Illness
Recent studies have associated human Metapneumovirus (HMPV) infection in children with respiratory disease of similar severity as respiratory syncytial virus (RSV) infection.
James A. Mullins +7 more
doaj +1 more source
Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice
Human metapneumovirus (HMPV) is an important cause of acute respiratory tract infection and causes significant morbidity and mortality. There is no specific antiviral drug to treat HMPV or vaccine to prevent HMPV.
Harrison C. Bergeron +4 more
doaj +1 more source
Human Metapneumovirus and Severity of Respiratory Syncytial Virus Disease
We screened 23 children with severe respiratory syncytial virus (RSV) disease and 23 children with mild RSV disease for human metapneumovirus (HMPV). Although HMPV was circulating in Connecticut, none of the 46 RSV-infected patients tested positive for ...
Isaac Lazar +5 more
doaj +1 more source
Background Human metapneumovirus (hMPV), a recently identified virus, causes acute respiratory tract infections (ARTIs) in infants and children. However, studies on the seroepidemeology of hMPV are very limited in China.
Wu Jiang +8 more
doaj +1 more source
Human metapneumovirus (HMPV): A brief overview
Human metapneumovirus (HMPV), discovered in 2001, is a significant respiratory pathogen in the Paramyxoviridae family that is responsible for substantial global morbidity and mortality. Despite its clinical impact, HMPV remains underdiagnosed and lacks specific treatments and vaccines.
openaire +1 more source

